View all live events
National Jewish Health in the Community
Educational Collaborations with Local and Regional Impact
National Jewish Health is working with local and regional health networks to address knowledge, competence and performance gaps in the areas of asthma, COPD and atopic dermatitis. Through three educational initiatives supported by GlaxoSmithKline and one by Pfizer, Professional Education provides evidence-based education to more than 200 providers and more than 300 medical staff who treat medically underserved, uninsured and underinsured patients in Colorado. Read more.
Assessing Asthma Control to Improve Patient Outcomes
GOLD Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: A new paradigm for COPD assessment and management
Knowledge and Outcomes in Rheumatoid Arthritis and its Cardiovascular Manifestations: Closing the Gap
View all online courses
Supraglottic Index Learning Program
The Supraglottic Index Learning Program is intended to educate pulmonologists and allergists on anatomy and abnormalities of the supraglottic area to help in phenotyping refractory asthma in order to direct specific personalized therapy for their patients.
Intended audience: Pulmonologists, allergists, ENT, PA, NP, and other health care professionals who treat patients with asthma (in particular, refractory) and have a possibility of high reflux
Topic areas: Respiratory and GI
Medical subject(s): Laryngopharyngeal reflux, microaspiration
Continue to CME Program